MOLECULAR CLONING AND ANALYSIS OF TUMOR-ASSOCIATED ANTIGENS
MOLECULAR CLONING AND ANALYSIS OF TUMOR-ASSOCIATED ANTIGENS
批准号:
3916369
负责人:
J KANTOR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
中文摘要
在我们实验室和其他实验室进行的研究表明,
TAG-72和CEA肿瘤相关抗原的存在,
高比例的人类癌症。 我们的研究集中在
了解这些分子在肿瘤发生中的作用
因为了解了
调节这些抗原的表达。 特异性探针
CEA基因家族的成员将被用于研究他们的
在各种组织和细胞系中的表达,并检查
干扰素调控CEA表达的机制
作为其他生物反应调节剂。 此外,该基因
将编码CEA的基因克隆并转染到小鼠转移瘤中,
细胞系,以获得用于研究抗-
肿瘤因子
去糖基化TAG-72的多克隆抗血清和
天然TAG-72的抗体将用于从cDNA获得克隆
图书馆. 将对阳性克隆进行测序并用于分析
TAG-72在正常和肿瘤细胞系和组织中的表达。
英文摘要
Studies carried out in our lab as well as others have demonstrated
the presence of the TAG-72 and CEA tumor associated antigens in a
high percentage of human carcinomas. Our studies have focused on
understanding the role of these molecules in tumorigenesis as well
as understanding the molecular mechanisms involved in the
regulation of expression of these antigens. Specific probes for
members of the CEA gene family will be used to study their
expression in various tissues and cell lines and to examine the
mechanism of regulation of CEA expression by interferons as well
as other biological response modifiers. In addition, the gene
encoding CEA will be cloned and transfected into mouse metastatic
cell lines in order to obtain a mouse model for the study of anti-
tumor agents.
Polyclonal antisera to deglycosylated TAG-72 and monoclonal
antibodies to native TAG-72 will be used to obtain clones from cDNA
libraries. Positive clones will be sequenced and used for analysis
of TAG-72 expression in normal and tumor cell line and tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISOLATION AND CHARACTERIZATION OF GENES CODING FOR CARCINOMA-ASSOCIATED ANTIGENS
-
批准号:3813405
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:2468459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
ACTIVE IMMUNOTHERAPY TO HUMAN CARCINOMA ASSOCIATED ANTIGENS
-
批准号:3808563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
ACTIVE IMMUNOTHERAPY TO HUMAN CARCINOMA ASSOCIATED ANTIGENS
-
批准号:3796509
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:6100941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:3752070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:6161041
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:5200983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
MOLECULAR CLONING OF TUMOR ASSOCIATED ANTIGENS
-
批准号:3939340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:3774358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
海外基金